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Hemorrhagic parapneumonic effusion in a 64 year-old patient
as the first symptom of hemophilia B
Abstract
Hemophilia B is an inherited, X chromosome-linked disease. It is usually diagnosed in childhood, sometimes in adolescence.
The commonest symptoms include spontaneous or post-traumatic bleeding into the joints and/or muscles, as well as
mucosal bleeding. Respiratory symptoms are rarely reported.
We present the case of a 64 year-old man in whom bloody parapneumonic effusion (hemothorax) was the first symptom of
hemophilia B. The reason for prolonged activated partial thromboplastin time (APTT) found on admission has not been
elucidated. Since antibiotic therapy and pleural tube thoracostomy with intrapleural streptokinase were found to be ineffec-
tive, video-assisted thoracic surgery was performed with the right lung decortication. Post-operative treatment was compli-
cated by massive pleural bleeding requiring two subsequent thoracotomies. Additional blood tests revealed factor IX
deficiency and resulted in hemophilia B being diagnosed.
The presented case proves that hereditary bleeding disorders may be diagnosed even in late adulthood. Intrapleural bleeding
related to pneumonia and pleural inflammation might be the first presenting symptom. Hemophilia should be considered as
a potential cause of APTT prolongation, even in an elderly patient with atypical presentation. Explaining the reason for APTT
prolongation before the surgical procedure could have allowed to avoid severe bleeding in the described patient.
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Introduction
Hemothorax is defined as the presence of blood
in the pleural cavity. As in many cases blood mi-
xes with pleural fluid, a criterion of the pleural flu-
id hematocrit ≥ 50% of peripheral blood hemato-
crit was introduced in the diagnosis of this condi-
tion [1]. The most frequent cause of hemothorax is
chest trauma, including iatrogenic manipulation
(surgical or diagnostic procedures).
Spontaneous (non-traumatic) hemothorax re-
sults mainly from primary or secondary pleural
malignancies. Other causes include a rupture of the
thoracic vessels (e.g. aortic aneurysm or pulmonary
arteriovenous fistula), or sub-diaphragmatic abdo-
minal vessels (e.g. splenic artery aneurysm) [1],
spontaneous pneumothorax, catamenial hemotho-
rax or inflammatory diseases (tuberculosis, necro-
tizing pneumonia). In rare cases, bleeding into the
pleural cavity may also result from anatomical
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anomalies [2], chickenpox pneumonia [3] and con-
nective-tissue diseases [4].
Other conditions leading to non-traumatic
hemothorax are inherited or acquired coagulation
disorders (hemophilia, thrombocytopenia, antico-
agulant therapy) [5]. However, in some patients,
the cause of hemothorax remains unknown [6, 7].
We present the case of an adult man hospita-
lized due to bloody, parapneumonic pleural effu-
sion classified as hemothorax, in whom, after de-
tailed diagnostic work-up, a congenital deficiency
of factor IX (hemophilia B) was recognized. This
deficiency seemed to be the main cause of pneu-
monia-associated pleural bleeding and post-surgi-
cal hemorrhagic complications.
Case report
A 64 year-old man with right-sided pneumonia
was admitted to our department with a ten day hi-
story of cough, pleuritic chest pain and elevated body
temperature. On the fifth day of the symptoms’ du-
ration, ambulatory antibiotic therapy (amoxicillin
clavulanate) had been administered without any
effect. Radiological progression was observed (pleu-
ral effusion had appeared).
On admission, the patient was in a good condi-
tion. His vital signs were: body temperature of 37.8°C,
respiratory rate of 18 breaths per min and a heart rate
of 100 bpm. Physical examination revealed signs of
right-sided pleural effusion and a systolic murmur
over the aortic valve and apex. His past history inc-
luded arterial hypertension, aortic valve disease (mo-
derate valve insufficiency and mild stenosis), coro-
nary artery disease complicated by a myocardial in-
farction three years ago, cardiac arrhythmia (paro-
xysmal atrial fibrillation and premature ventricular
contractions), spine osteoarthritis and duodenal pep-
tic ulcer disease. Four years earlier, the patient had
undergone surgical treatment for hemorrhoids. The-
re was no previous history of respiratory disease or
chest trauma. The patient was an active smoker
(25 pack-years), but denied alcohol abuse. He was
treated with perindopril, sotalol and atorvastatin.
The chest radiograph performed on admission
revealed a loculated pleural effusion in the ante-
ro-lateral region of the right pleural cavity with
a lung consolidation above the fluid level (Figs. 1A,
B). Laboratory investigations showed an elevated
erythrocyte sedimentation rate (ESR, 125 mm/h)
and C-reactive protein concentration (CRP 204 mg/l;
normal value < 10 mg/l), WBC count of 10.42 × 103/µl
(neutrophils — 61.2%, lymphocytes — 24.2%, eosi-
nophils — 1.8%, basophils — 0.4%, monocytes
— 12.4%), normocytic anemia (hemoglobin concen-
tration 11.10 g/dl), increased transaminase activity
(AST 59 U/l, normal range 5–40 U/l; ALT 70 U/l,
normal range 7–56 U/l), prolonged APTT 45.5 s,
(normal range 26–38 s). Prothrombin time and pla-
telet count were in the normal range. Arterial blo-
od gas analysis revealed hypoxemia (PaO2 68.0 mm
Hg), hypocapnia (PaCO2 33.8 mm Hg) and slight
respiratory alkalosis (pH 7.46).
Antibiotic therapy was continued (amoxicil-
lin clavulanate intravenously). Additionally
a mucolytic agent was added and respiratory reha-
bilitation initiated. Moreover, acetylosalicylic acid
(75 mg/day) was administered due to the history
of coronary artery disease and myocardial infarct.
Ultrasonography (US) confirmed the presen-
ce of an encapsulated right-sided pleural effusion
(65 × 60 mm) adhering to the chest wall between
the right parasternal line and anterior axillary line.
A thick layer of clots and thin septa within were
revealed (Fig. 2). US-guided thoracentesis was per-
formed and 40 ml of bloody fluid evacuated. La-
boratory studies showed pleural fluid pH 7.4, lac-
tate dehydrogenase (LDH) 940 U/l, glucose 74 mg/dl,
Figure 1. Chest X-ray on admission PA (A) and right lateral (B)
A
B
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with lymphocyte predominance (55%) and granu-
locytes 37%. Neither the total cell count nor the
hematocrit of the fluid were assessed due to the
presence of clots.
On the basis of the clinical manifestation, and
additional examination results, right-sided pneu-
monia with parapneumonic effusion was diagno-
sed. A closed-tube drainage was initiated and an in-
trapleural fibrynolytic agent (streptokinase 250 000 U)
was administered as standard treatment of locula-
ted parapneumonic effusion. Circa 500 ml of bloody
effusion (Ht 20%) was drained during the first
24 hours. However, on the second day the chest
tube had to be removed due to its occlusion by fi-
brinous tissue.
Afterwards, epistaxis and tawny sputum were
observed. Otolaryngological examination and
bronchofiberoscopy failed to identify the source of
bleeding. Subsequently, a decrease in the hemo-
globin concentration (9.0 g/dl) was noted. The ul-
trasound appearance of the right pleural effusion
did not change significantly. However, in the chest
computed tomography the encapsulated pleural
effusion was found not only adjacent to the chest
wall, but also in the paramediastinal and sub-pul-
monic regions and in the interlobar fissure (Fig. 3).
The pleura was thickened (5 mm) and the hetero-
geneous fluid attenuation (39 to 73 HU) suggested
the presence of blood. Resolving infiltrates in the
middle lobe were noted. A second thoracentesis
was performed and 20 ml of bloody effusion obta-
ined for examination (fluid HGB level 13.6 g/dl, Ht
23.2%, RBC 3.08 × 106/µl). Subsequently, the pa-
tient had a transfusion of two units of packed red
blood cells.
Over the following days, a deterioration in the
patient’s general condition (fever up to 38.8°C,
chills) and an increase of serum CRP concentra-
tion, were observed. In order to exclude a superin-
fection of the pleural effusion, another thoracen-
tesis was performed. The pleural fluid did not have
a purulent appearance, but the microbiological
examination revealed the presence of Staphylococ-
cus aureus. Since the previously applied tube tho-
racostomy was considered ineffective, the patient
was scheduled for surgical treatment. However,
referral to the Department of Surgery was delayed
due to atrial fibrillation. Both pharmacological
(amiodarone) and electrical cardioversion failed to
restore the sinus rhythm. Therefore anticoagula-
tion therapy (enoxaparin 80 mg/d) and bisoprolol
for heart rate control was introduced.
In the Department of Surgery, video-assisted
thoracoscopic surgery (VATS) was performed with
right lung decortication and removal of the puru-
lent and fibrous material. In the early post-opera-
Figure 3. Chest CT scans (mediastinal window) showing encap-
sulated pleural effusion in different areas of the right pleural cavi-
ty: (1) adjacent to antero-lateral part of the chest wall, (2) para-




Figure 2. Pleural ultrasonography revealing loculated pleural effusion
with thick layer of clots (large arrow) and thin septa (small arrow) within
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tive period, bleeding to the right pleural cavity was
observed, therefore a thoracotomy and re-thoraco-
tomy within 36 hours after the first procedure was
performed. No source of the recurrent bleeding was
found. Packed red blood cells and fresh frozen pla-
sma were transfused. The cause of bleeding rema-
ined undetermined. Its association with acetylsa-
licylic acid intake and treatment with enoxaparin
seemed unlikely, as they were both withdrawn
before the operation. Therefore, a detailed exami-
nation of the blood coagulation system in a search
for coagulopathy was performed. The prothrombin
time was normal, no deficiency of either fibrino-
gen or vitamin K dependent factors (II, VII, VIII,
XI) was found. APTT was prolonged up to 44 sec.
In the mixture of 1 volume patient plasma with
1 volume of control plasma, APPT was in the normal
range. This result excluded the presence of an inhi-
bitor and indicated a deficiency of a clotting factor
in the intrinsic pathway of coagulation. Determined
factor IX activity was 21% (normal range 50–150%).
Therefore, mild hemophilia B was diagnosed.
Finally, the bleeding was stopped by factor IX
intravenous administration. The patient was trans-
ferred to our department for further treatment.
During the next few days, the pleural drainage
gradually decreased. Normal body temperature and
a slow reduction of serum CRP concentration were
observed. On the sixteenth day after the last surgi-
cal procedure, the chest tube was removed after
a prophylactic factor IX infusion. In the chest radio-
graph and pleural ultrasonography a small encap-
sulated pleural effusion adjacent to the lateral chest
wall was described. The patient was discharged and
referred for further treatment to the Institute of He-
matology and Transfusion Medicine. At a six-month
follow-up no recurrence of bleeding was observed
and a regression of the changes in the chest radio-
graph was noted.
Discussion
Hemophilia is a bleeding disorder inherited in
a sex-linked recessive pattern. The two main ty-
pes of the disease are caused by a deficiency of
clotting factors synthesized in the liver: factors VIII
(hemophilia A) and IX (hemophilia B). The genes
for these factors are located on the X chromoso-
me. Therefore hemophilia is transferred by fema-
les to male descendents. The prevalence of hemo-
philia in Poland is one case per 5600 males, and
the ratio of hemophilia A to B is 6.2:1 [6]. The cli-
nical manifestation of both entities is similar and
depends on the level of the factor VIII, or IX, defi-
ciency, respectively. In severe disease, the factor
(VIII or IX) activity is lower than 1%, in moderate
1–5%, and in mild 6–40%. The most typical symp-
tom for severe hemophilia is spontaneous bleeding
to joints and muscles. In moderate disease, spon-
taneous bleeding is less frequent and in mild he-
mophilia signs of coagulation disorders may be
absent [9, 10]. Bleeding after dental extraction or
tonsillectomy and bleeding associated with trau-
ma or surgical procedures occur in both types of
the disease [9–11]. Prolonged APTT is a typical
laboratory finding. The quantitative assessment of
the clotting factors’ activity (first factor VIII, then
IX) is mandatory.
Respiratory symptoms (e.g. hemoptysis) are
rare [9]. Although hemophilia may be a cause of
hemothorax, only a few such case reports can be
found in the literature [12–15]. They describe ca-
ses related mainly to hemophilia A. Rasaretnam et
al. presented a patient in whom the disease was
diagnosed during hemothorax therapy [12], while
Kay and Williams reported cases in which hemo-
philia A was recognized prior to the bleeding to
the pleural cavity [13, 14]. Barrett [15] not only
describes three cases of hemothorax in hemophi-
lic patients, but also presents a review of the lite-
rature from the first half of the twentieth century.
However, he does not mention the type of hemo-
philia involved. Case reports of hemothorax rela-
ted to spontaneous pneumothorax also affected
patients with hemophilia A [16]. To the best of our
knowledge, hemophilia B-associated hemothorax
was described only by Turiaf et al. [17].
In our reported case, bloody pleural effusion
was obtained during the very first thoracentesis.
However, the medical history was so suggestive for
pleuropneumonia, that we assumed that the presen-
ce of blood in the pleural fluid was related to the
thoracentesis itself. We also considered primary
hemothorax with subsequent bacterial infection.
However, no history of chest trauma and typical
evolution of the clinical manifestation made that
possibility unlikely. An association between intra-
pleural bleeding and streptokinase therapy seemed
unlikely, since intrapleural fibrinolysis does not
deteriorate blood coagulation. Moreover, intrapleu-
ral thrombolytic agents are used to improve the dra-
inage of a recent hemothorax [18]. However, single
cases of bleeding into the pleural cavity following
intrapleural fibrynolysis were described [19, 20]. In
our Department, therapy with thrombolytic agents
has been applied for 15 years and no hemorrhage
into pleural cavity has been observed (only a chan-
ge in the drained fluid color was noted).
In our patient with mild hemophilia B, ble-
eding could have been influenced by anti-coagu-
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lation therapy. Small doses of acetylsalicylic acid
(ASA) exceptionally cause serious bleeding. Howe-
ver, the risk of coagulation disorders is increased
in a hemophilic patient [21] or during therapy with
another anti-platelet agent [22]. It has been docu-
mented that acetylsalicylic acid does not increase
the risk of bleeding during fiberoptic bronchosco-
py or transbronchial biopsy [23]. However, simul-
taneous treatment with ASA and clopidogrel is
associated with an increased risk of bleeding com-
plications [24].
The potential influence of enoxaparin should
also be considered. The therapy was initiated to
decrease the risk of thromboembolism induced by
atrial fibrillation. This seemed to be the best treat-
ment option, as low weight molecule heparins
(LWMH) are easy to withdraw before surgery in
order to reduce the probability of bleeding during
the procedure and in the post-operative period.
However, in a patient with an undiagnosed, inhe-
rited coagulation disorder, the use of ASA, which
irreversibly inhibits platelets, together with
LWMH, could have enhanced the bleeding. An
intrapleural hemorrhage could have occurred after
thoracoscopy in a patient with mild hemophilia,
even without anticoagulant therapy.
Recurrent massive bleeding to the pleural ca-
vity following VATS with no evident source iden-
tified in thoracotomy and re-thoracotomy imposed
a detailed work-up of the blood coagulation sys-
tem and resulted in hemophilia B diagnosis. In our
opinion, the qualification for surgical treatment
was proper. The presence of Staphylococcus aureus
in a parapneumonic pleural fluid means a compli-
cated effusion and local therapy is the treatment
of choice [25, 26]. In case of an unsuccessful pleu-
ral drainage, surgical treatment is indicated. We
may assume that if in the early stages of the dise-
ase, the two main facts (bloody effusion and pro-
longed APTT) had been associated together, the co-
agulation disorder could have been identified ear-
lier and post-operative bleeding might have been
avoided.
Initially, we did not focus on the prolonged
APTT because of the negative history of coagula-
tion disorders and the age of the patient. Previously
reported cases of hemothorax in the course of he-
mophilia referred to patients aged under 30 [12, 16].
Mild hemophilia may be asymptomatic and
remain unrecognized. However, even minor sur-
gical procedures in these patients are associated
with an increased risk of bleeding if the clotting
factor is not administered prior to the procedure.
In the Polish population the diagnosed incidence of
severe hemophilia B is higher than in other Europe-
an countries (56.6 vs. 29–40%, respectively). This may
be explained by the fact that mild and moderate he-
mophilia remains underdiagnosed in our country.
We suspect that in our patient with mild he-
mophilia B, the infection of the lung tissue and
pleura resulted in a parapneumonic effusion and
spontaneous bleeding. Data in the literature on that
subject is scarce. ASA and LWMH therapy may
have enhanced the process. Surgical procedures
additionally increased the intrapleural bleeding.
Conclusion
Our case shows that a patient with a mild fac-
tor IX deficiency (hemophilia B) may reveal coagu-
lation disorders in adulthood (even in advanced
age) and respiratory symptoms may predominate
in the clinical manifestation. Prolonged APTT re-
quires explanation prior to surgical treatment be-
cause the outcome of the investigation may modi-
fy the therapeutic approach and help avoid hemor-
rhagic complications.
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